These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 31041582)

  • 1. Parkinson's disease and the gastrointestinal microbiome.
    Lubomski M; Tan AH; Lim SY; Holmes AJ; Davis RL; Sue CM
    J Neurol; 2020 Sep; 267(9):2507-2523. PubMed ID: 31041582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
    Dogra N; Mani RJ; Katare DP
    Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of the Gut Microbiome in Parkinson's Disease.
    Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
    Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
    O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
    Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
    Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
    Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
    J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
    Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease.
    Zhang W; Ye Y; Song J; Sang T; Xia T; Xie L; Qiu X; Zeng Q; Luo X
    J Integr Neurosci; 2023 Oct; 22(6):157. PubMed ID: 38176929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
    Nielsen SD; Pearson NM; Seidler K
    Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
    Alfonsetti M; Castelli V; d'Angelo M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
    Mahbub NU; Islam MM; Hong ST; Chung HJ
    Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut brain axis: an insight into microbiota role in Parkinson's disease.
    Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
    Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human gut microbiota and Parkinson's disease.
    Pant A; Bisht KS; Aggarwal S; Maiti TK
    Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease.
    Pavan S; Prabhu AN; Prasad Gorthi S; Das B; Mutreja A; Shetty V; Ramamurthy T; Ballal M
    Folia Microbiol (Praha); 2022 Oct; 67(5):693-706. PubMed ID: 35583791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
    Rajput C; Sarkar A; Sachan N; Rawat N; Singh MP
    Neurochem Res; 2021 Mar; 46(3):425-438. PubMed ID: 33400024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options.
    Chan DG; Ventura K; Villeneuve A; Du Bois P; Holahan MR
    J Parkinsons Dis; 2022; 12(8):2339-2352. PubMed ID: 36278360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment.
    Salim S; Ahmad F; Banu A; Mohammad F
    J Adv Res; 2023 Aug; 50():83-105. PubMed ID: 36332796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.